Weekly nab-paclitaxel is safe and effective in ≥65 years old patients with metastatic breast cancer: A post-hoc analysis

Authors:

Abstract
No abstract available
Funding Information
  • Abraxis BioScience

This publication has 21 references indexed in Scilit: